VANESSA DELGADO: Open Payments
NPI 1750034104 · OCALA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$219 in 10 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $42 · 2025 $219
Food & beverage: $219
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 3 | $73 |
| Lilly USA, LLC | 2 | $38 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $24 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
| Novo Nordisk Inc | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
| Amgen Inc. | 1 | $14 |
Products named: TRELEGY ELLIPTA, JARDIANCE, LEQVIO, AIRSUPRA, MOUNJARO, KISUNLA, OTEZLA.
Industry payments across FL — which companies pay providers there.
